Corona Remedies IPO GMP Listed Historical GMP record

Grey market premium history vs actual listing price

Corona Remedies IPO's final recorded GMP before listing was ₹300 per share (a 28% premium over the ₹1062 upper price band). The shares listed at ₹1470. GMP is unofficial and does not forecast or guarantee the actual listing price.

Corona Remedies IPO GMP vs actual listing price

Final recorded GMP+₹300
Indicative price (band + GMP)₹1,362
Actual listing price₹1,470
Listing price vs indicative+₹108

The indicative price was a grey-market calculation, not a forecast. The actual listing price is determined on the exchange and can differ materially from GMP-based figures.

Corona Remedies IPO GMP history (day-wise)

Last recorded grey-market quote for each day, newest first. Across the recorded period, Corona Remedies IPO GMP ranged from ₹55 to ₹320.

Day-wise recorded GMP for Corona Remedies IPO
Date GMP (₹) Change GMP % Indicative Listing (₹) = upper price band + GMP. Indicative only, not a forecast.
+₹300 ₹0 +28% ₹1,362
+₹300 +₹30 +28% ₹1,362
+₹270 −₹10 +25% ₹1,332
+₹280 +₹70 +26% ₹1,342
+₹210 −₹30 +20% ₹1,272
+₹240 −₹30 +23% ₹1,302
+₹270 −₹50 +25% ₹1,332
+₹320 +₹30 +30% ₹1,382
+₹290 +27% ₹1,352

Corona Remedies IPO details

Key details of Corona Remedies IPO
Price Band₹1008-1062
Lot Size14 shares
Issue SizeOffer For Sale : 61,71,101 shares(aggregating up to ₹655.37 Cr)
Listing AtBSE, NSE
Open DateDec 8, 2025
Close DateDec 10, 2025
Allotment DateDec 11, 2025
Listing DateDec 15, 2025

How IPO Ji updates GMP data

  • Source: GMP figures come from IPO Ji's informal-market data feed and are not exchange-published prices.
  • Calculation: GMP % = GMP ÷ upper price band × 100. Indicative listing price = upper price band + GMP.
  • Freshness: Timestamps are shown in IST and the page reflects the most recently recorded quote. A value without a reliable timestamp is not labelled “today” or “current”.
  • Editorial policy: IPO Ji reports the recorded figure without ranking IPOs or recommending an application decision.

GMP can change without notice and may differ materially from the actual listing price.

FAQs

Corona Remedies IPO GMP — Frequently Asked Questions

What was Corona Remedies IPO GMP before listing?

Corona Remedies IPO's final recorded GMP before listing was ₹300 per share (a 28% premium over the ₹1062 upper price band). The shares listed at ₹1470. GMP is unofficial and does not forecast or guarantee the actual listing price.

What is the indicative listing price of Corona Remedies IPO?

The indicative listing price of Corona Remedies IPO was ₹1362, calculated as the ₹1062 upper price band + ₹300 GMP. This figure is based on unofficial grey-market quotes; it is indicative only and not a forecast or guarantee of the actual listing price.

Is Corona Remedies IPO GMP a guarantee of the listing price?

No. GMP is unofficial, unregulated grey-market information and does not forecast or guarantee the actual listing price of Corona Remedies IPO. It can change quickly and may differ materially from the eventual exchange price. IPO Ji reports it for information only and does not deal in or facilitate grey-market transactions.

When will Corona Remedies IPO list?

Corona Remedies IPO has listed on Dec 15, 2025 on BSE, NSE. The shares listed at ₹1470.

How often is Corona Remedies IPO GMP updated?

The Corona Remedies IPO GMP on this page refreshes whenever a new grey-market figure is recorded in IPO Ji's data feed; the latest recorded quote is from 13 Dec 2025, 1:30 PM IST. Because the grey market is informal, figures are indicative and can change through the day.

Prefer updates on the go? The IPO Ji app shows IPO dates, GMP and subscription status in one place.